Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong.
Medtronic Completes Follow up in Arctic Front® Cryoballoon Clinical Trial for Paroxysmal Atrial Fibrillation
![StopAfib.org - For Patients. By Patients - Stop Atrial Fibrillation](https://www.stopafib.org/og-image.jpg)
Leave a Reply